An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and Toxicity
- 5 December 2007
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 377 (1) , 136-147
- https://doi.org/10.1016/j.jmb.2007.11.096
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced ToxicityJournal of Molecular Biology, 2007
- Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxinNature Biotechnology, 2006
- A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian MonkeysPublished by Elsevier ,2006
- Camelized Rabbit-derived VH Single-domain Intrabodies Against Vif Strongly Neutralize HIV-1 InfectivityJournal of Molecular Biology, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996